MOLOGEN Lifescience AG (FRA:U1DA)
Germany · Delayed Price · Currency is EUR 2.800
0.00 (0.00%)
Sep 16, 2026, 9:10 AM CET
MOLOGEN Lifescience AG Revenue
MOLOGEN Lifescience AG had revenue of 45.12K EUR in the twelve months ending June 30, 2022. In the year 2021, MOLOGEN Lifescience AG had annual revenue of 45.12K.
Revenue
45.12K
Revenue Growth
n/a
P/S Ratio
85.64
Revenue / Employee
45.12K
Employees
1
Market Cap
3.86M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 45.12K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | 15.52K | -81.48K | -84.00% |
| Dec 31, 2017 | 97.00K | 73.00K | 304.17% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Blue Cap AG | 136.46M |
| Pyramid AG | 74.23M |
| Laiqon AG | 43.86M |
| CR Energy AG | 15.22M |
| Scherzer & Co. AG | 12.71M |
| Bitcoin Group SE | 10.05M |
| Shareholder Value Beteiligungen AG | 7.12M |
| Heliad AG | 328.00K |